Verenium sells cellulosic-ethanol business to BP

BP Biofuels North America has agreed to purchase Verenium's cellulosic-biofuels unit, including facilities in Louisiana and California, for $98.3 million. The acquisition will make BP the sole investor in Vercipia Biofuels and Galaxy Biofuels, which were originally formed with Verenium. The transaction will also allow Verenium to concentrate on its enzyme business, said CEO Carlos Riva and Chief Operating Officer Janet Roemer.

View Full Article in:

Washington Post, The · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC